Ta Win makes foray into pharma industry, invests RM20.8m in Royce Pharma


From left are Royce Pharma Manufacturing president Zainal Ariff Tan Sri Mahmood and group deputy president Datuk Chandrasekar Suppiah; Deputy Human Resources Minister Awang Hashim Awang Hashim while Ta Win Holdings was presented by its group managing director Datuk Seri Ngu Tieng Ung and executive director Tan Poo Chuan.

KUALA LUMPUR: Ta Win Holdings Bhd’s subsidiary is venturing into the pharmaceutical industry through its RM20.85mil investment in Royce Pharma Manufacturing Sdn Bhd.

It said in a statement on Monday its healthcare arm Ta Win Copper Biohealth Sdn Bhd (TWCB) agreed to acquire a 32.5% stake in Royce Pharma, marking the first investment in the pharmaceutical industry.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Emerging Asia banks have buffers to withstand strong El Ni�o, says S&P
AI to drive Asean+3 growth
Khazanah’s Dana Impak mobilises RM2.6bil in investments
Gig workers, elderly need better social protection in Budget 2027 - World Bank
Malaysia's inflation among region's lowest, but upstream cost pressures rising - World Bank
Top Glove posts earnings surge in FY26, declares 1.5c div/share
Bursa Malaysia tracks regional markets higher at midday
AkzoNobel's US$1.35bil decorative paints sale to Nippon Paint to complete mid-2027
Scientex unit to acquire Pulai land for RM580.15mil
OCK partners JTower and Sun Phu Quoc to deploy telco infra supporting APEC 2027

Others Also Read